| Product NDC: | 0069-4170 |
| Proprietary Name: | ZMAX |
| Non Proprietary Name: | azithromycin dihydrate |
| Active Ingredient(s): | 2 g/60mL & nbsp; azithromycin dihydrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-4170 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050797 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950610 |
| Package NDC: | 0069-4170-02 |
| Package Description: | 60 mL in 1 BOTTLE (0069-4170-02) |
| NDC Code | 0069-4170-02 |
| Proprietary Name | ZMAX |
| Package Description | 60 mL in 1 BOTTLE (0069-4170-02) |
| Product NDC | 0069-4170 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | azithromycin dihydrate |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19950610 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | AZITHROMYCIN DIHYDRATE |
| Strength Number | 2 |
| Strength Unit | g/60mL |
| Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |